Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Half of the patients responded to their vaccine, producing immune cells that have persisted for nearly four years so far ...

To solve this critical challenge, he founded Nephrogen in 2022, a biotech startup that uses AI and advanced screening to ...

Professor David Williams, a New Zealander working on gene therapy at UCLA, has warned that the Bill is “unfair to farmers” and based on false assumptions about precision and safety. He points to ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.

Intellia Therapeutics has temporarily stopped dosing and patient screening in two late-stage studies of its gene therapy after a participant developed serious liver injury, the company said on Monday, ...

An increasing demand for gene therapies is focusing the industry on enhancing production capabilities, transitioning from ...

Mr Andrews contacted the medical team at Massachusetts General Hospital ( MGH) that had carried out the operation. On January ...

Sepsis ranks among the deadliest illnesses a child can face. It’s an infection that spirals out of control, causing organ ...

Intellia Therapeutics has paused dosing in its Phase 3 MAGNITUDE trials after a patient experienced severe liver toxicity, as ...